GGrantIndex
← Leaderboards

Ashutosh Chilkoti

Duke University

$32,367,884
Attributed
$38,658,510
Total exposure
31
Grants
24
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,561,121 · 30
CDC$1,097,389 · 1

By mechanism

R01$26,781,511 · 11
R21$2,479,855 · 6
R35$2,238,634 · 1
UH3$1,855,789 · 1
R61$1,620,643 · 1
R44$1,278,585 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Technology

Research focus

TechnologyPolymersDesignPharmaceutical PreparationsProteinsElastinTemperatureIn VivoPolypeptideExhibitsBaseRecombinantsPerformancePeptidesPhase TransitionAntibodiesSurfaceImageCellsBehaviorStructureCostIn VitroLength

Grant awards (112)

Scale-up and Toxicity Studies of POEGMA-Uricase$639,413
R44 · FY2025 · TR
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$556,460
R01 · FY2025 · AI
Next Generation Stealth Lipid for the Delivery of mRNA$314,347
R41 · FY2025 · AI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$138,564
R01 · FY2025 · AI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$726,999
R01 · FY2024 · AI
Scale-up and Toxicity Studies of POEGMA-Uricase$639,172
R44 · FY2024 · TR
A Fully Integrated Point-of-Care Test for Ebola$590,199
R01 · FY2024 · AI · contact PI
Point-of-care cellular and molecular pathology of breast tumors on a cell phone$560,028
R01 · FY2024 · CA · contact PI
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment$441,591
R01 · FY2024 · DK · contact PI
Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide Scaffold$296,151
R41 · FY2024 · NS
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$732,049
R01 · FY2023 · AI
A Fully Integrated Point-of-Care Test for Ebola$590,199
R01 · FY2023 · AI · contact PI
Point-of-care cellular and molecular pathology of breast tumors on a cell phone$584,964
R01 · FY2023 · CA · contact PI
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19$463,414
R01 · FY2023 · AI · contact PI
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment$460,492
R01 · FY2023 · DK · contact PI
A Fully Integrated Point-of-Care Test for Ebola$772,176
R01 · FY2022 · AI · contact PI
Point-of-care cellular and molecular pathology of breast tumors on a cell phone$602,938
R01 · FY2022 · CA · contact PI
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19$487,484
R01 · FY2022 · AI · contact PI
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment$465,178
R01 · FY2022 · DK · contact PI
Genetically Encoded Smart Biohybrid Materials$385,285
R35 · FY2022 · GM · contact PI
Acquisition of a Confocal Fluorescence Microscope to Image Synthetic Biomolecular Condensates$197,907
R35 · FY2022 · GM · contact PI
A Fully Integrated Point-of-Care Test for Ebola$717,426
R01 · FY2021 · AI · contact PI
Point-of-care cellular and molecular pathology of breast tumors on a cell phone$607,659
R01 · FY2021 · CA · contact PI
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment$512,934
R01 · FY2021 · DK · contact PI
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19$502,734
R01 · FY2021 · AI · contact PI
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer$453,359
UH3 · FY2021 · CA · contact PI
Rapid diagnosis and quantification of HIV by direct capture, labelling and detection of individual virions$444,310
R61 · FY2021 · AI
Genetically Encoded Smart Biohybrid Materials$385,285
R35 · FY2021 · GM · contact PI
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer$721,330
UH3 · FY2020 · CA · contact PI
A Fully Integrated Point-of-Care Test for Ebola$717,426
R01 · FY2020 · AI · contact PI
Point-of-care cellular and molecular pathology of breast tumors on a cell phone$581,490
R01 · FY2020 · CA · contact PI
Rapid diagnosis and quantification of HIV by direct capture, labelling and detection of individual virions$444,310
R61 · FY2020 · AI
Genetically Encoded Smart Biohybrid Materials$385,285
R35 · FY2020 · GM · contact PI
Rapid diagnosis and quantification of HIV by direct capture, labelling and detection of individual virions$287,713
R61 · FY2020 · AI
A novel sustained-release immunotoxin for treatment of glioblastoma multiforme$168,758
R21 · FY2020 · CA · contact PI
Genetically Encoded Smart Biohybrid Materials$116,150
R35 · FY2020 · GM · contact PI
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer$681,100
UH3 · FY2019 · CA · contact PI
Rapid diagnosis and quantification of HIV by direct capture, labelling and detection of individual virions$444,310
R61 · FY2019 · AI
Genetically Encoded Smart Biohybrid Materials$385,285
R35 · FY2019 · GM · contact PI
A novel sustained-release immunotoxin for treatment of glioblastoma multiforme$203,646
R21 · FY2019 · CA · contact PI
Point of Care Testing to Improve Monitoring of LVAD Patients$190,624
R21 · FY2019 · HL · contact PI
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer$385,158
UG3 · FY2018 · CA · contact PI
Genetically Encoded Smart Biohybrid Materials$383,437
R35 · FY2018 · GM · contact PI
Point of Care Testing to Improve Monitoring of LVAD Patients$229,922
R21 · FY2018 · HL · contact PI
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer$399,986
UG3 · FY2017 · CA · contact PI
Elastin Fusion Proteins$322,528
R01 · FY2017 · GM · contact PI
Development of a POEGMA-Aptamer rapid onset anticoagulant that eliminates antigenicity to anti-PEG antibodies$277,130
R41 · FY2017 · HL · contact PI
Elastin Fusion Proteins$322,925
R01 · FY2016 · GM · contact PI
Treating Melanoma with a Molecularly Engineered, Long Circulating Immunotoxin$198,750
R21 · FY2016 · EB · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$341,864
R01 · FY2015 · EB · contact PI
Thermally Triggered Multivalent Targeting of Tumors$336,458
R01 · FY2015 · EB · contact PI
Protease Operated Depot for Delivery of GLP-1$332,609
R01 · FY2015 · DK · contact PI
Elastin Fusion Proteins$323,308
R01 · FY2015 · GM · contact PI
Treating Melanoma with a Molecularly Engineered, Long Circulating Immunotoxin$238,500
R21 · FY2015 · EB · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$338,376
R01 · FY2014 · EB · contact PI
Site-Specific Growth of Stealth Polymer from Peptide Therapeutics$336,616
R01 · FY2014 · DK · contact PI
Thermally Triggered Multivalent Targeting of Tumors$333,305
R01 · FY2014 · EB · contact PI
Protease Operated Depot for Delivery of GLP-1$332,609
R01 · FY2014 · DK · contact PI
Elastin Fusion Proteins$314,072
R01 · FY2014 · GM · contact PI
POC 2-D Diffusion Assay for self-monitoring of BNP$177,631
R41 · FY2014 · HL · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$328,957
R01 · FY2013 · EB · contact PI
Site-Specific Growth of Stealth Polymer from Peptide Therapeutics$325,015
R01 · FY2013 · DK · contact PI
Thermally Triggered Multivalent Targeting of Tumors$324,293
R01 · FY2013 · EB · contact PI
Protease Operated Depot for Delivery of GLP-1$320,968
R01 · FY2013 · DK · contact PI
2-D Diffusion Assay on Polymer Brush for POC Cardiac Infarction Diagnosis$182,073
R21 · FY2013 · HL · contact PI
Site-Specific Growth of Stealth Polymer from Peptide Therapeutics$336,983
R01 · FY2012 · DK · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$336,016
R01 · FY2012 · EB · contact PI
Protease Operated Depot for Delivery of GLP-1$332,609
R01 · FY2012 · DK · contact PI
Thermally Triggered Multivalent Targeting of Tumors$331,343
R01 · FY2012 · EB · contact PI
Elastin Fusion Proteins$305,791
R01 · FY2012 · GM · contact PI
2-D Diffusion Assay on Polymer Brush for POC Cardiac Infarction Diagnosis$230,601
R21 · FY2012 · HL · contact PI
2012 Bioinspired Materials Gordon Research Conference$10,000
R13 · FY2012 · EB · contact PI
Site-Specific Growth of Stealth Polymer from Peptide Therapeutics$312,361
R01 · FY2011 · DK · contact PI
Elastin Fusion Proteins$305,791
R01 · FY2011 · GM · contact PI
Delivery of Peptide Therapeutics by Molecular Release Depots$181,752
R21 · FY2011 · EB · contact PI
Intravital point-scanning confocal microscope$499,775
S10 · FY2010 · RR · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$345,858
R01 · FY2010 · EB · contact PI
Thermally Triggered Multivalent Targeting of Tumors$345,858
R01 · FY2010 · EB · contact PI
Elastin Fusion Proteins$308,880
R01 · FY2010 · GM · contact PI
Delivery of Peptide Therapeutics by Molecular Release Depots$228,179
R21 · FY2010 · EB · contact PI
Detection of Biomolecules by Nanoscale Plasmon Ruler$193,050
R21 · FY2010 · EB · contact PI
Elastin Fusion Proteins$362,000
R01 · FY2009 · GM · contact PI
Thermally Triggered Multivalent Targeting of Tumors$349,351
R01 · FY2009 · EB · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$349,351
R01 · FY2009 · EB · contact PI
Detection of Biomolecules by Nanoscale Plasmon Ruler$234,000
R21 · FY2009 · EB · contact PI
Elastin Fusion Proteins$134,951
R01 · FY2009 · GM · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$349,351
R01 · FY2008 · EB · contact PI
Thermally Triggered Multivalent Targeting of Tumors$349,351
R01 · FY2008 · EB · contact PI
Elastin Fusion Proteins$242,718
R01 · FY2008 · GM · contact PI
Nanophotonics for Select Agent Detection$470,850
R01 · FY2007 · CI · contact PI
Thermally Triggered Multivalent Targeting of Tumors$350,719
R01 · FY2007 · EB · contact PI
Thermally Targeted Drug Delivery by Elastin Biopolymers$343,440
R01 · FY2007 · EB · contact PI
Elastin Fusion Proteins$242,718
R01 · FY2007 · GM · contact PI
Nanophotonics for Select Agent Detection$626,539
R01 · FY2006 · CI · contact PI
Elastin Fusion Proteins$249,967
R01 · FY2006 · GM · contact PI
2006 Biointerface Science$10,000
R13 · FY2006 · EB · contact PI
Thermally targeted drug delivery by elastin biopolymers$308,000
R01 · FY2005 · EB
Elastin Fusion Proteins$272,272
R01 · FY2005 · GM
Nanophotonics for Select Agent Detection$0
R01 · FY2005 · CI
Thermally targeted drug delivery by elastin biopolymers$306,191
R01 · FY2004 · EB
The AVS2004 Biomaterials Interfaces Symposium$10,000
R13 · FY2004 · EB
Nanophotonics for Select Agent Detection$0
R01 · FY2004 · CI
Thermally targeted drug delivery by elastin biopolymers$301,088
R01 · FY2003 · EB
ELASTIN FUSION PROTEINS$211,200
R01 · FY2003 · GM
Nanophotonics for Select Agent Detection$0
R01 · FY2003 · CI
Thermally targeted drug delivery by elastin biopolymers$297,200
R01 · FY2002 · EB
ELASTIN FUSION PROTEINS$211,200
R01 · FY2002 · GM
PATTERNING ANTIBODIES USING PHOTODEPROTECTION CHEMISTRY FOR MULTIANALYTE SENSOR$0
P41 · FY2002 · RR
ELASTIN FUSION PROTEINS$211,200
R01 · FY2001 · GM
PATTERNING ANTIBODIES USING PHOTODEPROTECTION CHEMISTRY FOR MULTIANALYTE SENSOR$0
P41 · FY2001 · RR
ELASTIN FUSION PROTEINS$234,057
R01 · FY2000 · GM
PATTERNING ANTIBODIES USING PHOTODEPROTECTION CHEMISTRY FOR MULTIANALYTE SENSOR$23,315
P41 · FY2000 · RR